RecruitingNCT07349498

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation (CORE-HCT): A Prospective Multicenter Observational Study

Sponsor

Peking University People's Hospital

Enrollment

10,000 participants

Start Date

Jan 1, 2026

Study Type

OBSERVATIONAL

Conditions

Hematopoietic Stem Cell Transplantation Cardiovascular Events Transplant Complication

Summary

This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.

Eligibility

Inclusion Criteria1

Patients who undergo hematopoietic cell transplantation at any of the participating medical centers.

Exclusion Criteria2

Any other conditions that, in the opinion of the investigator, can interfere with the interpretation of data.
Patient request to withdraw from the study.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(16)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

Peking University First Hospital

Beijing, Beijing Municipality, China

Peking University People's Hospital

Beijing, Beijing Municipality, China

Peking University Third Hospital

Beijing, Beijing Municipality, China

Xinqiao hospital of the third military medical university

Chongqing, Chongqing Municipality, China

Sun Yat-sen University Cancer Center, Sun Yat-sen University

Guangzhou, Guangdong, China

Peking University Shenzhen Hospital

Shenzhen, Guangdong, China

First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology

Wuhan, Hubei, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

First Affiliated Hospital Xi'an Jiaotong University

Xi'an, Shaanxi, China

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences)

Tianjin, Tianjin Municipality, China

First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

First Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07349498

Related Trials

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

NCT030002441 location

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

NCT050279451 location

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

NCT054364182 locations

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

NCT056055742 locations

Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation

NCT041468701 location